MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

09 Feb 2023 Evaluate
The Revenue for the quarter ended  December 2022 of Rs. 1488.04 millions grew by 22.72 % from Rs. 1212.54 millions.A big decline of -52.14% was reported for the quarter ended December 2022 to Rs. 50.28  millions from Rs. 105.06 millions of corresponding previous quarter.Operating profit for the quarter ended December 2022 decreased to 204.80 millions as compared to 294.10 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1488.04 1212.54 22.72 3726.26 4590.98 -18.84 5198.74 5631.78 -7.69
Other Income 22.14 21.30 3.94 36.29 46.29 -21.60 51.98 34.53 50.54
PBIDT 204.80 294.10 -30.36 350.86 1235.43 -71.60 1196.83 1245.63 -3.92
Interest 59.36 47.52 24.92 160.29 145.35 10.28 188.75 111.62 69.10
PBDT 145.44 246.58 -41.02 190.57 1090.08 -82.52 1008.08 1134.01 -11.10
Depreciation 81.25 80.96 0.36 241.51 241.81 -0.12 321.52 222.82 44.30
PBT 64.19 165.62 -61.24 -50.94 848.27 -106.01 686.56 911.19 -24.65
TAX 13.91 60.56 -77.03 -11.03 258.51 -104.27 6.18 301.55 -97.95
Deferred Tax 14.50 25.56 -43.27 -10.44 78.51 -113.30 -143.02 141.09 -201.37
PAT 50.28 105.06 -52.14 -39.91 589.76 -106.77 680.38 609.64 11.60
Equity 84.65 84.65 0.00 84.65 84.65 0.00 84.65 84.65 0.00
PBIDTM(%) 13.76 24.25 -43.26 9.42 26.91 -65.01 23.02 22.12 4.09
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..